XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Equity Incentive Plan | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Equity Incentive Plan | Equity Incentive Plans On May 22, 2019, the Northfield Bancorp, Inc. 2019 Equity Incentive Plan (the “2019 EIP”) was approved by stockholders of the Company. Under the 2019 EIP, the maximum number of shares of stock that may be delivered to participants in the form of stock options and stock appreciation rights (“SARs”) is 6,000,000. To the extent an equity award is issued in the form of a restricted stock grant, or restricted stock unit, the number of stock options/SARs that can be granted is reduced by 4.5. The maximum number of shares of stock that may be delivered to participants in the form of restricted stock awards and restricted stock units is 1,333,333 shares. As of December 31, 2021, a total of 4,737,701 stock options, SARs and restricted stock awards or restricted stock units remained available for issuance under the 2019 EIP, of which the maximum number of restricted stock awards and restricted stock units available for issuance was 1,052,822. Prior to May 22, 2019, the Company also maintained the Northfield Bancorp, Inc. 2014 Equity Incentive Plan (the “2014 EIP”) which allowed the Company to grant common stock or options to purchase common stock at specific prices to directors and employees of the Company. The 2014 EIP provided for the issuance or delivery of up to 4,978,249 shares (1,422,357 restricted shares and 3,555,892 stock options) of Northfield Bancorp, Inc. common stock subject to certain plan limitations. Upon approval of the 2019 EIP, the 2014 EIP was frozen and equity awards that would otherwise have been available for issuance were no longer available for grant, however, options previously granted under the 2014 EIP still remain outstanding and exercisable. There were no stock options granted in 2021, 2020 or 2019. During the years ended December 31, 2021, 2020, and 2019, the Company recorded, $994,000, $1.4 million, and $3.2 million of stock-based compensation, respectively. The following table is a summary of the Company’s stock options as of December 31, 2021, and changes therein during the year then ended:
| Number of Stock Options |  | Weighted Average Grant Date Fair Value |  | Weighted Average Exercise Price |  | Weighted Average Contractual Life (years)
Outstanding- December 31, 2019 | 2,227,193 |  |  | $ | 4.01 |  |  | $ | 13.93 |  |  | 4.96
Exercised | (13,000) |  |  | 3.93 |  |  | 13.38 |  |  | — |
Outstanding- December 31, 2020 | 2,214,193 |  |  | 4.01 |  |  | 13.94 |  |  | 3.96
Forfeited | (50,169) |  |  |  |  | 13.62 |  |  |
Exercised | (394,045) |  |  | 3.96 |  |  | 13.90 |  |  | — |
Outstanding- December 31, 2021 | 1,769,979 |  |  | 4.02 |  |  | 13.95 |  |  | 2.95
Exercisable- December 31, 2021 | 1,769,979 |  |  | $ | 4.02 |  |  | $ | 13.95 |  |  | 2.95
There was no remaining future stock option expense related to the options outstanding as of December 31, 2021, as all are vested. On January 29, 2021, the Company granted to directors and employees, under the 2019 Equity Incentive Plan, 147,315 restricted stock units with a total grant-date fair value of $1.8 million. Of these grants, 32,769 vest one year from the date of grant and 114,546 vest in equal installments over a five-year period beginning one year from the date of grant. The Company also issued 29,615 performance-based restricted stock units to its executive officers with a total grant date fair value of $366,041. Vesting of the performance-based restricted stock units will be based on achievement of certain levels of Core Return on Average Assets and will cliff-vest after a three-year measurement period ended January 29, 2024, based on the Company's performance relative to a peer group as determined by the Compensation Committee of the Board. At the end of the performance period, the number of actual shares to be awarded may vary between 0% and 225% of target amounts. On February 17, 2020, the Company granted to directors and employees, under the 2019 EIP, 83,744 restricted stock units with a total grant-date fair value of $1.3 million. Of these grants, 28,460 vest one year from the date of grant and 55,284 vest in equal installments over a five-year period beginning one year from the date of grant. The Company also issued 19,837 performance-based restricted stock units to its executive officers with a total grant date fair value of $313,623. Vesting of the performance-based restricted stock units will be based on achievement of certain levels of Core Return on Average Assets and will cliff-vest after a three-year measurement period ended December 31, 2022, based on the Company's performance relative to a peer group as determined by the Compensation Committee of the Board. At the end of the performance period, the number of actual shares to be awarded may vary between 0% and 225% of target amounts. The following is a summary of the status of the Company’s restricted shares as of December 31, 2021, and changes therein during the year then ended:
| Number of Shares Awarded |  | Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019 | 71,102 |  |  | $ | 15.36 |
Granted | 103,581 |  |  | 15.81 |
Vested | (67,100) |  |  | 15.18 |
Forfeited | (3,573) |  |  | 15.81 |
Non-vested at December 31, 2020 | 104,010 |  |  | 15.91 |
Granted | 176,930 |  |  | 12.36 |
Vested | (42,470) |  |  | 16.06 |
Forfeited | (15,626) |  |  | 13.80 |
Non-vested at December 31, 2021 | 222,844 |  |  | $ | 13.21 |
Expected future stock award expense related to the non-vested restricted awards as of December 31, 2021, is $1.7 million over an average period of 3.42 years. Upon the exercise of stock options, management expects to utilize treasury stock as the source of issuance for these shares.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration